Stocks and Investing Stocks and Investing
Thu, October 21, 2021

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $134 on, Oct 21st, 2021


Published on 2024-10-27 18:15:20 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $128 to $134 on, Oct 21st, 2021.

Jayson has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021


These are the ratings of the 6 analyists that currently disagree with Jayson


  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, October 20th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021

Contributing Sources